Richmond、VAにおける脂肪肝の臨床試験
Richmondとその周辺地域（約30マイル以内）の拠点で、脂肪肝に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
被験者募集中第3相
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
被験者募集中第3相
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
被験者募集中第2相
- Virginia Commonwealth University, Richmond
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
被験者募集中第2相
- Richmond Veterans Administration Medical Center, Richmond
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
被験者募集中第3相
- Richmond Veterans Affairs Medical Center (Richmond VA Medical Center), Richmond
- Virginia Commonwealth University (VCU) Medical Center, Richmond
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
被験者募集中第3相
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- 他1件
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
被験者募集中第2相
- GI Alliance Richmond, Richmond
- GI Select Health Research, Richmond
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
被験者募集中第2相
- GSK Investigational Site, Richmond
- GSK Investigational Site, Richmond
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
被験者募集中第2相
- GSK Investigational Site, Richmond
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
被験者募集中第2相
- Virginia Commonwealth University, Richmond
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
被験者募集中
- Virginia Common wealth University, Richmond
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
被験者募集中観察研究
- Virginia Commonwealth University, Richmond
他の都市における脂肪肝の試験
- San Antonio, TX17件の研究
- Miami, FL16件の研究
- New York City, NY16件の研究
- San Diego, CA14件の研究
- Austin, TX13件の研究
- Houston, TX13件の研究
- Chandler, AZ10件の研究
- Tucson, AZ10件の研究
- St. Louis, MO9件の研究
- Dallas, TX9件の研究
- Orlando, FL9件の研究
- Hialeah, FL9件の研究
Richmondにおける他の研究
- 乳がん26件の研究
- 非小細胞肺癌25件の研究
- 前立腺がん19件の研究
- 心不全16件の研究
- 肺がん14件の研究
- 心血管疾患13件の研究
- 大腸癌13件の研究
- 急性骨髄性白血病12件の研究
- 転移性癌12件の研究
- 頭頸部扁平上皮癌12件の研究
- 悪性黒色腫11件の研究
- 肥満症11件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。